-
Taxonomy & unit
-
us-gaap: USD
-
Description
-
The aggregate amount of income or expense from ancillary business-related activities (that is to say, excluding major activities considered part of the normal operations of the business).
-
Summary
-
Mycotopia Therapies, Inc. quarterly/annual Nonoperating Income (Expense) history and growth rate from Q2 2018 to Q2 2024.
- Mycotopia Therapies, Inc. Nonoperating Income (Expense) for the quarter ending June 30, 2024 was -$79.3K, a 50.9% increase year-over-year.
- Mycotopia Therapies, Inc. Nonoperating Income (Expense) for the twelve months ending June 30, 2024 was -$390K, a 48.9% increase year-over-year.
- Mycotopia Therapies, Inc. annual Nonoperating Income (Expense) for 2023 was -$565K, a 35.5% increase from 2022.
- Mycotopia Therapies, Inc. annual Nonoperating Income (Expense) for 2022 was -$876K, a 477% decline from 2021.
- Mycotopia Therapies, Inc. annual Nonoperating Income (Expense) for 2021 was -$152K, a 8295% decline from 2020.
Nonoperating Income (Expense), Trailing 12 Months (USD)
Nonoperating Income (Expense), Quarterly (USD)
Nonoperating Income (Expense), YoY Quarterly Growth (%)